FI20011446A0 - A pharmaceutical composition containing brivudine for once daily administration - Google Patents

A pharmaceutical composition containing brivudine for once daily administration

Info

Publication number
FI20011446A0
FI20011446A0 FI20011446A FI20011446A FI20011446A0 FI 20011446 A0 FI20011446 A0 FI 20011446A0 FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A FI20011446 A FI 20011446A FI 20011446 A0 FI20011446 A0 FI 20011446A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
composition containing
once daily
daily administration
containing brivudine
Prior art date
Application number
FI20011446A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20011446A (en
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Richerche S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Richerche S P A filed Critical Berlin Chemie Ag
Publication of FI20011446A0 publication Critical patent/FI20011446A0/en
Publication of FI20011446A publication Critical patent/FI20011446A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
FI20011446A 2001-01-03 2001-07-03 Pharmaceutical brivudine containing composition taken once daily FI20011446A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number Publication Date
FI20011446A0 true FI20011446A0 (en) 2001-07-03
FI20011446A FI20011446A (en) 2002-07-04

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011446A FI20011446A (en) 2001-01-03 2001-07-03 Pharmaceutical brivudine containing composition taken once daily

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
DE69726255T2 (en) * 1996-01-19 2004-08-26 Glaxo Group Ltd., Greenford USE OF VALACICLOVIR FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GENITALHERPES BY ADMINISTRIAL DAILY ADMINISTRATION

Also Published As

Publication number Publication date
ES2192456B1 (en) 2005-02-01
HUP0102816A3 (en) 2005-01-28
HUP0102816A2 (en) 2002-10-28
SK287043B6 (en) 2009-10-07
BE1014522A5 (en) 2003-12-02
HRPK20010345B3 (en) 2005-02-28
SE0102309D0 (en) 2001-06-28
GR20010100322A (en) 2002-10-08
ES2192456A1 (en) 2003-10-01
FR2818907B1 (en) 2006-05-26
IE20010413A1 (en) 2003-04-16
FR2818907A1 (en) 2002-07-05
PT102642A (en) 2002-07-31
FI20011446A (en) 2002-07-04
PT102642B (en) 2003-06-30
GB2370771A (en) 2002-07-10
DK177084B1 (en) 2011-07-11
CZ20012464A3 (en) 2002-08-14
AT6141U1 (en) 2003-05-26
ITMI20010009A0 (en) 2001-01-03
ITMI20010009A1 (en) 2002-07-03
GB0110682D0 (en) 2001-06-20
NL1018431C2 (en) 2002-07-05
SK9572001A3 (en) 2003-03-04
GR1004012B (en) 2002-11-01
PL348480A1 (en) 2002-07-15
HRP20010345A2 (en) 2003-08-31
CH695662A5 (en) 2006-07-31
UA76402C2 (en) 2006-08-15
SE0102309L (en) 2002-07-04
DK200101019A (en) 2002-07-04
HU0102816D0 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
GB0117618D0 (en) Pharmaceutical dosage form
NO20030627D0 (en) Hydrogel-driven drug dosage form
NO20022970D0 (en) Hydrogel-driven drug dosage form
NO20024175L (en) Acetidine derivatives, their preparation and pharmaceutical compositions containing the compounds
HK1059573A1 (en) Olopatadine formulations for topical administration.
FI20011478A (en) Pharmaceutical composition
EE200300523A (en) Aripiprazole oral solution for oral administration
ATE468324T1 (en) PHARMACEUTICAL COMPOSITION
AT7729U3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEAT
GB0117619D0 (en) Pharmaceutical dosage form
DK1383482T3 (en) Process for Preparing a Low Dosage Pharmaceutical Composition
ATA59499A (en) PHARMACEUTICAL PREPARATION CONTAINING TOLPERISON FOR ORAL ADMINISTRATION
ATE324883T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
NO20034556D0 (en) Imidazotriazinone-containing compositions for nasal administration
FI20022128A (en) Pharmaceutical composition
ATE348599T1 (en) DRONEDARON PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION
ATE350016T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
ATE366128T1 (en) PHARMACEUTICAL COMPOSITION
DE10291905D2 (en) Pharmaceutical composition
FI20011446A0 (en) A pharmaceutical composition containing brivudine for once daily administration
ATE350029T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
EE200300378A (en) A pharmaceutical composition
MXPA01005658A (en) Brivudin-containing daily pharmaceutical composition.
DE50008261D1 (en) RETARDED PHARMACEUTICAL FORM CONTAINING TRAMADOLSACCHARINATE

Legal Events

Date Code Title Description
FD Application lapsed